Shingles Vaccine Shows Promise in Reducing Dementia Risk

A recent study indicates that the shingles vaccine can reduce dementia risk by 20%. Women seem to benefit more than men from this protection. The research involved analyzing health records from over 280,000 older adults in Wales. If confirmed, the vaccine could serve as a preventive intervention against dementia.

A shingles vaccine may significantly lower the risk of developing dementia, potentially reducing it by a fifth, especially benefiting women, suggests a study led by Stanford University.

The research delved into the health records of more than 280,000 adults in Wales, highlighting a 20% relative risk reduction in dementia among those vaccinated.

Experts noted the findings could influence public health strategies by advocating wider adoption of the shingles vaccine as a preventive measure against dementia.